Patau syndrome

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC
| Patau syndrome | |
|---|---|
| Synonyms | Trisomy 13, Trisomy D |
| Pronounce | |
| Specialty | Medical genetics |
| Symptoms | Cleft lip and palate, polydactyly, microcephaly, holoprosencephaly, congenital heart defects |
| Complications | N/A |
| Onset | Prenatal |
| Duration | Lifelong |
| Types | N/A |
| Causes | Trisomy 13 |
| Risks | Advanced maternal age |
| Diagnosis | Karyotype |
| Differential diagnosis | Edwards syndrome, Down syndrome |
| Prevention | |
| Treatment | Supportive care |
| Medication | |
| Prognosis | Poor, with most affected individuals not surviving past infancy |
| Frequency | 1 in 10,000 to 1 in 21,700 live births |
| Deaths | |
Introduction[edit]
Patau syndrome, also known as Trisomy 13, is a genetic disorder characterized by the presence of an extra copy of chromosome 13 in some or all of an individual's cells. Normally, individuals have two copies of each chromosome, one inherited from each parent. However, in Patau syndrome, individuals have three copies of chromosome 13. This extra genetic material disrupts normal development, leading to a range of severe physical and intellectual abnormalities.


Genetics of Patau Syndrome[edit]
The extra copy of chromosome 13 in Patau syndrome usually results from a process called nondisjunction, where cellular mechanisms fail to properly separate the chromosomes during the formation of reproductive cells (gametes). This results in an egg or sperm cell with an extra copy of chromosome 13. If such a cell contributes to the formation of an embryo, the resulting individual will have three copies of chromosome 13 in each cell. Less commonly, Patau syndrome can result from a translocation, where a piece of chromosome 13 becomes attached to another chromosome. In such cases, individuals may have two normal copies of chromosome 13, but they also have additional material from chromosome 13 attached to another chromosome.
Clinical Manifestations[edit]
Patau syndrome leads to a wide array of abnormalities that can affect almost every part of the body:
- Neurological and Craniofacial Features: These include intellectual disability, microcephaly (a smaller than normal head size), and structural brain abnormalities. Facial features may include close-set eyes, small eye openings, a small mouth, and low-set ears.
- Eye Abnormalities: Structural defects such as microphthalmia (abnormally small eyes), anophthalmia (absence of one or both eyes), and retinal dysplasia are common.
- Limb and Digit Abnormalities: Individuals may have extra fingers or toes (polydactyly) and other limb abnormalities including a notable decrease in muscle tone (hypotonia).
- Other Features: Heart defects are common, as are abnormalities of the kidneys and other organs.
Diagnosis and Management[edit]
Patau syndrome is often diagnosed prenatally through screening tests such as ultrasound and amniocentesis, which can detect the presence of an extra chromosome 13. After birth, the diagnosis can be confirmed through a blood test called a chromosomal karyotype, which can visualize the presence of trisomy 13. Management of Patau syndrome focuses on supportive care and addressing the individual's specific symptoms, as there is no cure for the condition. Children with Patau syndrome often need a team of specialists to address their complex medical needs.
Prognosis[edit]
Patau syndrome is typically associated with severe health problems and a shortened lifespan. Many affected individuals do not survive past the first few weeks or months of life due to the serious health problems associated with the condition. However, some individuals with less severe forms of the condition can live into adolescence or adulthood with appropriate supportive care.
|
|
|
| Chromosome abnormalities | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
References[edit]
- Cereda A, Carey JC. The trisomy 13 syndrome. Orphanet Journal of Rare Diseases. 2012;7:74.
- Parker SE, Mai CT, Canfield MA, et al. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol. 2010;88(12):1008-1016.
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

